AnodyneWiki

Cannabidiol

CBD
Cannabidiol
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass314.50 g/mol [1]
Predicted LogP6.5 [1]
Structural Identifiers
[]
Molecular formulaC21H30O2
IUPAC name2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol
SMILESCCCCCC1=CC(=C(C(=C1)O)[C@@H]2C=C(CC[C@H]2C(=C)C)C)O
InChIInChI=1S/C21H30O2/c1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h11-13,17-18,22-23H,2,5-10H2,1,3-4H3/t17-,18+/m0/s1
InChIKeyQHMBSVQNZZTUGM-ZWKOTPCHSA-N
CAS number13956-29-1
UNII19GBJ60SN5
PubChem CID644019
Pharmacokinetics[]
Elimination half-life18–32 hours[3]
Routes of administrationBy mouth, sublingual, buccal, inhalation[4][5]
Addiction liabilityNone[6]

Cannabidiol (also known as (-)-Cannabidiol, (-)-trans-Cannabidiol, Epidiolex, Δ1(2)-trans-Cannabidiol, Gwp42003-p, cannabidiolum, Cardiolrx, (-)-trans-2-p-Mentha-1,8-dien-3-yl-5-pentylresorcinol, NanoCDB or Melody Cloverstrip) is a cannabinoid and opioid substance of the phenol and benzochromene class.

Chemistry

 []

Cannabidiol is a single defined stereoisomer (optical activity ( - )).

Cannabidiol matches Lipinski's rule of five (violations: 1).

There are currently 12 reagent-interactions on

ReagentColor changeDescription
Marquisdark brown > black
Meckedark brown > black
Mandelindark brown > black
Liebermannorange > brown
Froehdebrown
Robadopeno pink color change
Simon'sno blue color change
Ehrlichpurple
Hofmannorange
Morrispale green
Zimmermannfast purple
Cannabis (4-AP)pink / purple

Pharmacology

Mechanism of action []

The exact mechanism of action of CBD and THC is not currently fully understood. However, it is known that CBD acts on cannabinoid (CB) receptors of the endocannabinoid system, which are found in numerous areas of the body, including the peripheral and central nervous systems, including the brain. The endocannabinoid system regulates many physiological responses of the body including pain, memory, appetite, and mood. More specifically, CB1 receptors can be found within the pain pathways of the brain and spinal cord where they may affect CBD-induced analgesia and anxiolysis, and CB2 receptors have an effect on immune cells, where they may affect CBD-induced anti-inflammatory processes. CBD has been shown to act as a negative allosteric modulator of the cannabinoid CB1 receptor, the most abundant G-Protein Coupled Receptor (GPCR) in the body. Allosteric regulation of a receptor is achieved through the modulation of the activity of a receptor on a functionally distinct site from the agonist or antagonist binding site. The negative allosteric modulatory effects of CBD are therapeutically important as direct agonists are limited by their psychomimetic effects while direct antagonists are limited by their depressant effects. [1]

Interactions []

Interaction mechanisms documented in (number of interacting drugs):

metabolism / inhibition / induction86
metabolism / inhibition / induction24
transporter inhibition / transporter induction22
metabolism2
metabolism1

Subjective effects []

0xea / Cannabidiol []
Routes:
  • Oral
Effects:Notes:
  • CYP2D6 Inhibition unconfirmed
a1ko / Cannabidiol []
Routes:
  • Oral
  • Smoked
alina / Cannabidiol []
Routes:
  • Oral (15.0mg)
bonzi / Cannabidiol []
magnus / Cannabidiol []
Routes:
  • Vaporized
Pilz / Cannabidiol []
Routes:
  • Oral
  • Smoked
Effects:

Experience reports

Erowid

There are currently 17 experience reports involving cannabidiol on : []

Reddit

There are currently 39 trip reports involving cannabidiol on : []

 []

  • Australia: Cannabidiol is a Schedule 4.
  • Brazil: Cannabidiol is a Synthetic: C3; Oil with <0,2% THC: B1; Oil <30mg/ml THC and <30mg/ml CBD: A3.[7]
  • Canada: Cannabidiol is Unscheduled.
  • Germany: Cannabidiol is a Anlage III under the "Betäubungsmittelgesetz (BtMG)".
  • New Zealand: Cannabidiol is Unscheduled.
  • United Kingdom: Cannabidiol is a GSL.
  • United States: Cannabidiol is Prescription only as Epidiolex; Unscheduled if derived from hemp with <0.3% Δ<sup>9</sup>-THC, Schedule III if derived from cannabis with >0.3% THC when dispensed from a state-licensed medical dispensary.[8][9][10]
  • European Union: Cannabidiol is Prescription only and OTC in some member states.

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 644019, Cannabidiol. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/644019
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Cannabidiol. UNII: 19GBJ60SN5. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/19GBJ60SN5
  3. Devinsky O, Cilio MR, Cross H, Fernandez-Ruiz J, French J, Hill C, Katz R, Di Marzo V, Jutras-Aswad D, Notcutt WG, Martinez-Orgado J, Robson PJ, Rohrback BG, Thiele E, Whalley B, Friedman D. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia. June 2014; 55(6):791–802. PMID 24854329. https://doi.org/10.1111/epi.12631
  4. Epidiolex – cannabidiol solution. DailyMed. August 26, 2020. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8bf27097-4870-43fb-94f0-f3d0871d1eec
  5. Sativex (Cannabidiol/Tetrahydrocannabinol) Bayer Label. bayer.ca. https://omr.bayer.ca/omr/online/sativex-pm-en.pdf
  6. Schedules of Controlled Substances: Placement in Schedule V of Certain FDA-Approved Drugs Containing Cannabidiol; Corresponding Change to Permit Requirements. Federal Register, US Federal Government. September 28, 2018. https://www.federalregister.gov/documents/2018/09/28/2018-21121/schedules-of-controlled-substances-placement-in-schedule-v-of-certain-fda-approved-drugs-containing
  7. RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. July 24, 2023. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451
  8. DEA announces steps necessary to improve access to marijuana research. DEA. August 26, 2019. https://www.dea.gov/press-releases/2019/08/26/dea-announces-steps-necessary-improve-access-marijuana-research
  9. Laurence E. Your Guide To CBD Legalization By State. Forbes Health. May 31, 2022. https://www.forbes.com/health/cbd/cbd-legalization-by-state/
  10. Justice Department Places FDA-Approved Marijuana Products and Products Containing Marijuana Subject to a Qualifying State-issued License in Schedule III, Strengthening Medical Research While Maintaining Strict Federal Controls. Office of Public Affairs. 23 April 2026. https://www.justice.gov/opa/pr/justice-department-places-fda-approved-marijuana-products-and-products-containing-marijuana

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 14:31:11
drugsprook2026-11-20 14:31:07
erowidok2026-11-20 14:31:10
gsrsok2026-11-20 14:31:08
hmdbmissing (no HMDB id)2026-11-20 14:31:07
keggok2026-11-20 14:31:09
pubchemok2026-11-20 14:31:07
redditok2026-11-20 14:31:07
sidermissing (not in SIDER)2026-11-20 14:31:07
structureok2026-11-20 14:31:07
wikipediaok2026-11-20 14:31:07